Abstract:The development of a highly efficient, low-toxicity, ultrasmall ferrite nanoparticle-based T-1 contrast agent for high-resolution magnetic resonance imaging (MRI) is highly desirable. However, the correlations between the chemical compositions, in vitro T-1 relaxivities, in vivo nano-bio interactions and toxicities remain unclear, which has been a challenge in optimizing the in vivo T-1 contrast efficacy. Methods: Ultrasmall (3 nm) manganese ferrite nanoparticles (MnxFe3-xO4) with different doping concentrations of the manganese ions (x = 0.32, 0.37, 0.75, 1, 1.23 and 1.57) were used as a model system to investigate the composition-dependence of the in vivo T-1 contrast efficacy. The efficacy of liver-specific contrast-enhanced MRI was assessed through systematic multiple factor analysis, which included the in vitro T1 relaxivity, in vivo MRI contrast enhancement, pharmacokinetic profiles (blood half-life time, biodistribution) and biosafety evaluations (in vitro cytotoxicity testing, in vivo blood routine examination, in vivo blood biochemistry testing and H&E staining to examine the liver). Results: With increasing Mn doping, the T-1 relaxivities initially increased to their highest value of 10.35 mM(-1)s(-1), which was obtained for Mn0.75Fe2.25O4, and then the values decreased to 7.64 m M(-1)s(-1), which was obtained for the Mn1.57Fe1.43O4 nanoparticles. Nearly linear increases in the in vivo MRI signals (Delta SNR) and biodistributions (accumulation in the liver) of the MnxFe3-xO4 nanoparticles were observed for increasing levels of Mn doping. However, both the in vitro and in vivo biosafety evaluations suggested that MnxFe3-xO4 nanoparticles with high Mn-doping levels (x > 1) can induce significant toxicity. Conclusion: The systematic multiple factor assessment indicated that the MnxFe3-xO4 (x = 0.75-1) nanoparticles were the optimal T-1 contrast agents with higher in vivo efficacies for liver-specific MRI than those of the other compositions of the MnxFe3-xO4 nanoparticles. Our work provides insight into the optimization of ultrasmall ferrite nanoparticle-based T-1 contrast agents by tuning their compositions and promotes the translation of these ultrasmall ferrite nanoparticles for clinical use of high-performance contrast-enhanced MRI.

Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents

A Contrast Examination of Proinflammatory Effects on Kidney Function for γ-Fe2O3 NP and Gadolinium Dimeglumine

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

Toxicological Risk Assessments of Iron Oxide Nanocluster- and Gadolinium-Based T1MRI Contrast Agents in Renal Failure Rats

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Ultrahigh Relaxivity and Safe Probes of Manganese Oxide Nanoparticles for in Vivo Imaging.

In Vivo Evaluation of Innovative Gadolinium-Based Contrast Agents Designed for Bioimaging Applications

Iron Oxide Nanoclusters for T 1 Magnetic Resonance Imaging of Non-Human Primates

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

Gadolinium-based contrast agents for tumor targeting imaging

Iron Oxide Nanoparticles in the Application of Magnetic Resonance Imaging

Surface impact on nanoparticle-based magnetic resonance imaging contrast agents

Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.

Toxicity Evaluation of Gd2O3@SiO2 Nanoparticles Prepared by Laser Ablation in Liquid As MRI Contrast Agents in Vivo

Manganese Oxide Nanoparticles As MRI Contrast Agents in Tumor Multimodal Imaging and Therapy

Safety evaluation of graphene oxide-based magnetic nanocomposites as MRI contrast agents and drug delivery vehicles

Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in male mice

Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their In Vivo T 1 Contrast Efficacy.

Carbonized Paramagnetic Complexes of Mn (II) As Contrast Agents for Precise Magnetic Resonance Imaging of Sub-Millimeter-sized Orthotopic Tumors

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics